Transabdominal Cerclage
Customize your policy alerts
Sign up for Aetna Policy 0529 alerts
Get alerted when Policy 0529 changes without checking for updates manually.
Monitor payer policy activity
Clinical policy governing when transabdominal cerclage is considered medically necessary or experimental for treatment of cervical incompetence; applies to Aetna members and providers submitting claims or prior authorization for the procedure.
No material clinical or coverage changes in this revision.
Coverage Criteria — Transabdominal Cerclage
Medically Necessary Indications
Aetna considers transabdominal cerclage medically necessary for the treatment of an incompetent cervix when ANY of the following are present:
History consistent with incompetent cervix must be documented (eg, mid-trimester pregnancy loss with painless cervical dilatation without uterine activity).
History consistent with incompetent cervix must be documented (eg, mid-trimester pregnancy loss with painless cervical dilatation without uterine activity).
History consistent with incompetent cervix must be documented (eg, mid-trimester pregnancy loss with painless cervical dilatation without uterine activity).
History consistent with incompetent cervix must be documented (eg, mid-trimester pregnancy loss with painless cervical dilatation without uterine activity).
Experimental / Investigational
Aetna considers transabdominal cerclage experimental and investigational for ALL other indications, including but not limited to:
Examples include prophylactic cerclage for multiple gestations; see policy text.
Indications and timing for TAC
Covered when ALL of the following are met (per source recommendations and study populations):
Based on SMFM recommendation and cohort inclusion criteria
SMFM guidance and cohort study timing (preconceptional and first-trimester placements reported)
SMFM recommendation and outcomes from laparoscopic and open series
ICD-10 codes for multiple gestation (listed as O30.001 - O30.93) are designated as not covered for the indications in this Clinical Policy Bulletin.
Available reviews and guidance indicate the role of cerclage in twin and higher-order multiple pregnancies is limited and uncertain. Some small case series report improved perinatal outcomes with transabdominal cerclage (TAC) in selected twin pregnancies, but larger reviews and authoritative summaries (UpToDate) recommend avoiding cerclage in twin or higher-order multiple pregnancies or consider the intervention unproven. Consequently, TAC for multiple gestations is considered unproven/not recommended except when meeting the policy's specific medically necessary indications.
This Clinical Policy Bulletin is a general, partial description of plan benefits and coverage considerations for transabdominal cerclage. It does not constitute a contract, guarantee coverage, or replace member-specific plan language. Coverage decisions depend on the member’s specific plan provisions and documented medical necessity per the policy criteria.
Use of transabdominal cerclage for indications other than those listed as medically necessary in this policy — for example, prophylactic placement for multiple gestations — is considered experimental and investigational due to insufficient evidence of effectiveness and would not be supported by this policy.
Specifically, prophylactic cerclage in women with triplet pregnancy who do not have a prior history of cervical insufficiency is described in reviews as unproven and is not recommended; studies do not show benefit and some suggest possible harm in multiples without prior cervical insufficiency.
Coding — CPT and ICD-10
| N88.3 | Incompetence of cervix uteri |
| O34.30 - O34.33 | Maternal care for cervical incompetence |
| O34.40 - O34.43 | Maternal care for other abnormalities of cervix [shortened, amputated, or deep traumatized cervix] |
| O30.001 - O30.93 | Multiple gestation |
Provider Actions — Authorization, Documentation, and Billing
Prior Authorization Not Specified
Prior authorization is not specifically described in the source CPB. Confirm with the payer whether a prior authorization (PA) is required for transabdominal cerclage (TAC) prior to scheduling the procedure.
- Action: Verify PA requirement with Aetna before scheduling.
If Prior Authorization Is Required
When prior authorization is required, ensure the request includes documentation that meets the medical necessity criteria in this CPB (see Clinical history and evaluation). If PA processes are maintained separately by the plan, follow the payer’s published PA submission and coding rules.
Step Therapy Not Specified
Step therapy or other utilization management (e.g., required trial of alternate therapies) is not specified in this CPB. Confirm with the plan if any step requirements apply.
- Action: Do not assume step therapy; verify with plan if needed.
Clinical History and Evaluation (Documentation)
Document the patient’s clinical history and evaluation thoroughly to support medical necessity: prior failed transvaginal cerclage(s), history of mid‑trimester painless losses consistent with cervical incompetence, or anatomic cervical abnormalities (shortened <2.5 cm, amputated, or deeply traumatized cervix). Include results of any evaluations (e.g., ultrasound findings, screening for antiphospholipid syndrome, infection screening) and prior operative reports.
- Specify dates and outcomes of prior TVC attempts and any complications.
- Include obstetric history (gestational ages of prior losses/deliveries).
- Attach relevant imaging, pathology, and laboratory results.
Position in Treatment Pathway
Position TAC in the treatment pathway: TAC is intended for patients with cervical insufficiency after failed transvaginal cerclage or when TVC is not possible (preconceptional or first trimester placement is acceptable; may be considered up to 22 weeks in some cases). Approach (laparoscopic vs open) may be chosen based on gestational age, technical feasibility, resources and surgical expertise.
- SMFM guidance: offer TAC for prior TVC with subsequent singleton delivery before 28 weeks.
- Document counseling with maternal-fetal medicine when applicable.
Denial Risk — Indication Outside Policy
TAC is considered medically necessary only for the specific indications listed in the CPB; use outside those indications (for example, prophylactic cerclage for multiple gestations) is considered experimental/investigational and may be denied. Ensure documentation ties the procedure to an accepted indication to reduce denial risk.
Background and Clinical Context
Cervical incompetence (incompetent cervix) is characterized by gradual, painless dilation in the mid‑trimester leading to membrane bulging or pregnancy loss; when transvaginal cerclage is not feasible or has failed, a transabdominal cerclage (TAC) — an encircling suture placed via laparotomy or laparoscopy above the level of the uterosacral/cardinal ligaments — may be used to provide mechanical support and reduce recurrent mid‑trimester pregnancy loss.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.